Merck & Co To Break New Ground With Female-Led Organon Unit

Former Chair And CEO Of Humacyte, Carrie Cox To Serve As Chair

 
• By Dean Rudge
  
Merck
Merck aims to complete the planned spin-off of its Organon unit “late in the second quarter." • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business